Edition:
United Kingdom

NantKwest Inc (NK.OQ)

NK.OQ on NASDAQ Stock Exchange Global Select Market

4.88USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
76,547
52-wk High
$8.43
52-wk Low
$2.71

Select another date:

Tue, Jul 25 2017

BRIEF-Nantkwest announces publication of preclinical data of hank cell therapy

* Nantkwest announces publication of preclinical data of hank cell therapy in combination with checkpoint inhibitor avelumab providing strong rationale for advancement to human clinical trials Source text for Eikon: Further company coverage:

Select another date: